Holen Sie sich die Stockscreener-App
3.50
1.96%
-0.08
Handel nachbörslich:
3.51
0.010
+0.29%
Schlusskurs vom Vortag:
$3.58
Offen:
$3.55
24-Stunden-Volumen:
3.39M
Relative Volume:
1.07
Marktkapitalisierung:
$390.60M
Einnahmen:
$2.05B
Nettoeinkommen (Verlust:
$-128.18M
KGV:
-2.2299
EPS:
-1.5696
Netto-Cashflow:
$-68.67M
1W Leistung:
+37.11%
1M Leistung:
+13.59%
6M Leistung:
-63.36%
1J Leistung:
-59.98%
1-Tages-Spanne:
$3.40
$3.64
1-Wochen-Bereich:
$2.50
$3.64
52-Wochen-Spanne:
$2.50
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.50 | 399.53M | 2.05B | -128.18M | -68.67M | -1.5696 |
|
VEEV
Veeva Systems Inc
|
186.20 | 29.83B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.40 | 9.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.64 | 7.50B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
80.43 | 6.66B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.04 | 4.75B | 550.17M | 201.35M | 232.07M | 1.00 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-13 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Cowen Maintains Buy on Evolent Health (EVH) March 2026, PT Cut to $7 - Meyka
TD Cowen cuts Evolent Health stock price target to $7 on 2026 outlook - Investing.com
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Evolent Health (EVH) Receives Updated Analyst Rating from Oppenh - GuruFocus
Oppenheimer Adjusts Evolent Health Price Target to $6 From $12, Maintains Outperform Rating - marketscreener.com
Evolent Health Charts Growth Amid 2026 Margin Squeeze - TipRanks
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Evolent Health (NYSE:EVH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Evolent Health and iRhythm Shares Are Falling, What You Need To Know - Finviz
Is Evolent Health Inc affected by consumer sentimentTrade Risk Assessment & Risk Managed Investment Signals - baoquankhu1.vn
Evolent to Participate in Upcoming Investor Conferences - The Malaysian Reserve
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Evolent Health downgraded at KeyBanc on EBITDA recovery concerns - MSN
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Citigroup - MarketBeat
UBS Maintains Evolent Health (EVH) Rating, Lowers Price Target | - GuruFocus
UBS Group Lowers Evolent Health (NYSE:EVH) Price Target to $5.00 - MarketBeat
Privia Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Evolent Health: Cheap, Levered, But Ready To Rebound (NYSE:EVH) - Seeking Alpha
UBS Adjusts Evolent Health Price Target to $5 From $10, Maintains Buy Rating - marketscreener.com
Truist Cuts Price Target on Evolent Health to $6 From $10, Keeps Buy Rating - marketscreener.com
Privia Health (PRVA) Q4 2025 Earnings Transcript - AOL.com
Evolent Health, Inc. (NYSE:EVH) Q4 2025 Earnings Call Transcript - Insider Monkey
Evolent Health (EVH) Shares Skyrocket, What You Need To Know - Finviz
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Truist cuts Evolent Health stock price target to $6 on 2026 outlook - Investing.com Australia
Evolent Health (EVH) Rating Maintained But Price Target Drastica - GuruFocus
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Needham & Company LLC - MarketBeat
RBC Capital Lowers Price Target for Evolent Health (EVH) by 40% - GuruFocus
Royal Bank Of Canada Cuts Evolent Health (NYSE:EVH) Price Target to $3.00 - MarketBeat
RBC Capital Adjusts Evolent Health PT to $3 From $5, Maintains Sector Perform Rating - marketscreener.com
KeyCorp Downgrades Evolent Health (NYSE:EVH) to Sector Weight - MarketBeat
BTIG Research Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
EVH: Keybanc Downgrades Evolent Health to Sector Weight | EVH St - GuruFocus
This First Solar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Evolent Health, Inc. SEC 10-K Report - TradingView
EVH: BTIG Lowers Price Target to $8, Maintains Buy Rating | EVH Stock News - GuruFocus
EVH | Evolent Health, Inc Class FinancialsIncome Statement - Quiver Quantitative
Evolent Health Q4 Loss Of US$3.84 Per Share Tests Bullish Margin Turnaround Narrative - Sahm
Evolent Health Inc earnings beat by $0.03, revenue fell short of estimates - Investing.com Australia
Evolent Health Q4 Earnings Call Highlights - MarketBeat
KeyBanc downgrades Evolent Health stock rating on leverage concerns - Investing.com Australia
Evolent Health Inc (EVH) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
Evolent Health Q4 2025 Earnings: Revenue Meets Forecasts, EPS Beats EstimatesNews and Statistics - IndexBox
Compared to Estimates, Evolent Health (EVH) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Evolent Health (EVH) Q4 Earnings Top Estimates - Yahoo Finance
Evolent Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:EVH) 2026-02-24 - Seeking Alpha
Evolent Health (EVH) outlines specialty care and risk-based growth strategy - Stock Titan
Evolent Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
EVOLENT HEALTH ($EVH) Releases Q4 2025 Earnings - Quiver Quantitative
Evolent Health (NYSE:EVH) Issues Earnings Results - MarketBeat
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.37%
4.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):